AMGN
Price
$280.43
Change
+$2.94 (+1.06%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
151.69B
41 days until earnings call
OGN
Price
$9.99
Change
+$0.04 (+0.40%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
4.73B
48 days until earnings call
Interact to see
Advertisement

AMGN vs OGN

Header iconAMGN vs OGN Comparison
Open Charts AMGN vs OGNBanner chart's image
Amgen
Price$280.43
Change+$2.94 (+1.06%)
Volume$43.46K
Capitalization151.69B
Organon & Co
Price$9.99
Change+$0.04 (+0.40%)
Volume$28.83K
Capitalization4.73B
AMGN vs OGN Comparison Chart in %
Loading...
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMGN vs. OGN commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Buy and OGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (AMGN: $277.49 vs. OGN: $9.95)
Brand notoriety: AMGN: Notable vs. OGN: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 131% vs. OGN: 52%
Market capitalization -- AMGN: $151.69B vs. OGN: $4.73B
AMGN [@Pharmaceuticals: Major] is valued at $151.69B. OGN’s [@Pharmaceuticals: Major] market capitalization is $4.73B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 0 FA rating(s) are green whileOGN’s FA Score has 0 green FA rating(s).

  • AMGN’s FA Score: 0 green, 5 red.
  • OGN’s FA Score: 0 green, 5 red.
According to our system of comparison, AMGN is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 6 TA indicator(s) are bullish while OGN’s TA Score has 6 bullish TA indicator(s).

  • AMGN’s TA Score: 6 bullish, 4 bearish.
  • OGN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, OGN is a better buy in the short-term than AMGN.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а -4.33% price change this week, while OGN (@Pharmaceuticals: Major) price change was +1.02% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.52%. For the same industry, the average monthly price growth was +4.77%, and the average quarterly price growth was +8.25%.

Reported Earning Dates

AMGN is expected to report earnings on Aug 05, 2025.

OGN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.52% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMGN($152B) has a higher market cap than OGN($4.73B). AMGN has higher P/E ratio than OGN: AMGN (22.66) vs OGN (4.64). AMGN YTD gains are higher at: 8.833 vs. OGN (-31.927). AMGN has higher annual earnings (EBITDA): 14.8B vs. OGN (1.44B). AMGN has more cash in the bank: 10.9B vs. OGN (693M). OGN has less debt than AMGN: OGN (8.76B) vs AMGN (64.6B). AMGN has higher revenues than OGN: AMGN (28.2B) vs OGN (6.26B).
AMGNOGNAMGN / OGN
Capitalization152B4.73B3,214%
EBITDA14.8B1.44B1,031%
Gain YTD8.833-31.927-28%
P/E Ratio22.664.64489%
Revenue28.2B6.26B450%
Total Cash10.9B693M1,573%
Total Debt64.6B8.76B737%
FUNDAMENTALS RATINGS
AMGN: Fundamental Ratings
AMGN
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
36
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMGNOGN
RSI
ODDS (%)
Bullish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 6 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 20 days ago
55%
Bullish Trend 15 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 13 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CGUS36.310.42
+1.17%
Capital Group Core Equity ETF
BUFC39.380.12
+0.31%
AB Conservative Buffer ETF
BSJU25.870.07
+0.29%
Invesco BulletShares 2030 HY Corp Bd ETF
SHYD22.55-0.02
-0.09%
VanEck Short High Yield Muni ETF
TSL13.72-0.41
-2.90%
GraniteShares 1.25x Long Tsla Daily ETF

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+1.85%
PFE - AMGN
56%
Loosely correlated
+1.17%
GSK - AMGN
52%
Loosely correlated
+1.10%
NVS - AMGN
49%
Loosely correlated
+1.11%
ABBV - AMGN
49%
Loosely correlated
+0.97%
GILD - AMGN
46%
Loosely correlated
+0.95%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
+2.05%
BIIB - OGN
40%
Loosely correlated
+1.24%
AMGN - OGN
39%
Loosely correlated
+1.85%
LLY - OGN
39%
Loosely correlated
+0.97%
GSK - OGN
39%
Loosely correlated
+1.10%
SNY - OGN
35%
Loosely correlated
+0.50%
More